AUROPHARMA
💊 AUROPHARMA responds to Zentiva buzz
Denies reports of a $5.5B Zentiva buyout
No binding agreement has been reached
👉 Stock in focus as company quashes deal speculation.
#StockInNews#WatchOutFor
789 likes·45 comments
Popular topics to explore